{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:11:44Z","timestamp":1785352304799,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","prrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.prrv.2017.06.012","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T21:17:18Z","timestamp":1497993438000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Treatment of narcolepsy and other organic hypersomnias in children"],"prefix":"10.1016","volume":"25","author":[{"given":"Suresh","family":"Kotagal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2017.06.012_b0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5665\/sleep.4582","article-title":"Psychiatric comorbidity and cognitive profile in children with narcolepsy with or without association to the H1N1 influenza vaccination","volume":"38","author":"Szakacs","year":"2015","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.prrv.2017.06.012_b0010","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.5665\/sleep.5970","article-title":"Psychosocial profile and quality of life in children with type 1 narcolepsy: a case control study","volume":"39","author":"Rocca","year":"2016","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.prrv.2017.06.012_b0015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/sleep\/30.11.1417","article-title":"Running promotes wakefulness and increases cataplexy in orexin knockout mice","volume":"30","author":"Espana","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.prrv.2017.06.012_b0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.sleep.2012.11.021","article-title":"Management of narcolepsy during pregnancy","volume":"14","author":"Thorpy","year":"2013","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.prrv.2017.06.012_b0025","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1592\/phco.29.6.656","article-title":"Attention-deficit disorder: an update","volume":"29","author":"Dopheide","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.prrv.2017.06.012_b0030","series-title":"Narcolepsy. A clinical guide","first-page":"307","article-title":"Modes of action of drugs related to narcolepsy: pharmacology of wake-promoting compounds and anticataplectics","author":"Nishino","year":"2016"},{"issue":"12","key":"10.1016\/j.prrv.2017.06.012_b0035","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Standards of practice committee of the AASM. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.prrv.2017.06.012_b0040","unstructured":"Product information: dextroamphetamine sulfate oral tablets, dextroamphetamine sulfate oral tablets. St. Louis, MO: Mallinckrodt; 2007."},{"key":"10.1016\/j.prrv.2017.06.012_b0045","unstructured":"Product information: RITALIN\u00ae oral tablets, methylphenidate hydrochloride oral tablets. East Hanover, NJ: Novartis; 2007."},{"key":"10.1016\/j.prrv.2017.06.012_b0050","series-title":"Narcolepsy. A clinical guide","first-page":"331","article-title":"Modafinil\/armodafinil in the treatment of narcolepsy","author":"Thorpy","year":"2016"},{"key":"10.1016\/j.prrv.2017.06.012_b0055","unstructured":"Product information: PROVIGIL\u00ae oral tablets, modafinil oral tablets. Frazer, PA: Cephalon Inc.; 2007."},{"issue":"4","key":"10.1016\/j.prrv.2017.06.012_b0060","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.prrv.2017.06.012_b0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00002826-200309000-00009","article-title":"Dosing regimen effects of modafinil improving daytime wakefulness in patients with narcolepsy","volume":"26","author":"Schwartz","year":"2003","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"10.1016\/j.prrv.2017.06.012_b0070","first-page":"293","article-title":"A review of modafinil film-coated tablets for attention deficit\/hyperactivity disorder in children and adolescents","volume":"3","author":"Rugino","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.1016\/j.prrv.2017.06.012_b0075","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1389-9457(03)00162-X","article-title":"Modafinil in the treatment of excessive daytime sleepiness in children","volume":"4","author":"Ivanenko","year":"2003","journal-title":"Sleep Med"},{"issue":"11","key":"10.1016\/j.prrv.2017.06.012_b0080","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomized trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"issue":"13","key":"10.1016\/j.prrv.2017.06.012_b0085","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s40265-016-0620-1","article-title":"Pitolisant: first global approval","volume":"76","author":"Syed","year":"2016","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.prrv.2017.06.012_b0090","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ejpn.2014.07.009","article-title":"Successful treatment of cataplexy in patients with Niemann Pick disease type C: use of tricyclic antidepressants","volume":"18","author":"Cak","year":"2014","journal-title":"Eur J Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.prrv.2017.06.012_b0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.sleep.2008.04.004","article-title":"Exacerbation of cataplexy following gradual withdrawal of antidepressants: manifestation of probable protracted rebound cataplexy","volume":"10","author":"Ristanovic","year":"2009","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.prrv.2017.06.012_b0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/14656566.2013.783021","article-title":"Pharmacotherapy options for cataplexy","volume":"14","author":"Lopez","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.prrv.2017.06.012_b0105","unstructured":"Product information: XYREM\u00ae oral solution, sodium oxybate oral solution. Palo Alto, CA: Jazz Pharmaceuticals, Inc. (per FDA); 2014."},{"key":"10.1016\/j.prrv.2017.06.012_b0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/sleep\/21.5.507","article-title":"Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients","volume":"21","author":"Scharf","year":"1998","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.prrv.2017.06.012_b0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.tpj.6500074","article-title":"A unique mouse model for succinic semialdehyde dehydrogenase deficiency with implications for gamma hydroxybutyrate intoxication","volume":"2","author":"Peters","year":"2002","journal-title":"J Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.prrv.2017.06.012_b0120","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jsr.12386","article-title":"Improved vigilance after sodium oxybate treatment in narcolepsy: a comparison between in-field and in-laboratory measures","volume":"25","author":"Van Schie","year":"2016","journal-title":"J Sleep Res"},{"issue":"8","key":"10.1016\/j.prrv.2017.06.012_b0125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/sleep\/29.8.1025","article-title":"Off-label treatment of severe narcolepsy-cataplexy with sodium oxybate","volume":"29","author":"Murali","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.prrv.2017.06.012_b0130","series-title":"Narcolepsy. A clinical guide","first-page":"341","article-title":"Sodium oxybate in the treatment of narcolepsy","author":"Mayer","year":"2016"},{"issue":"6","key":"10.1016\/j.prrv.2017.06.012_b0135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.sleep.2011.10.032","article-title":"Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study","volume":"13","author":"Mansukhani","year":"2012","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.prrv.2017.06.012_b0140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.5665\/sleep.1836","article-title":"Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study","volume":"35","author":"Lecendreux","year":"2012","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.prrv.2017.06.012_b0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.prrv.2017.06.012_b0150","unstructured":"de Oliveira MM, Conti C, Prado GF. Pharmacological treatment for Kleine Levin syndrome. Cochrane database of systematic reviews 6 May, 2016;25(4): 486\u201396\u2019. http:\/\/dx.doi.org\/10.1002\/14651858.CD006685.pub4.2016."},{"issue":"19","key":"10.1016\/j.prrv.2017.06.012_b0155","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1212\/WNL.0000000000002104","article-title":"Lithium therapy in Kleine-Levin syndrome: an open-label, controlled study in 130 patients","volume":"85","author":"Leu-Semenescu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.prrv.2017.06.012_b0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.24459","article-title":"Clarithromycin in \u0263-aminobutyric acid-related hypersomnolence: a randomized, cross-over trial","volume":"78","author":"Trotti","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.prrv.2017.06.012_b0165","series-title":"Narcolepsy. A clinical guide","first-page":"357","article-title":"Emerging treatments for narcolepsy","author":"Broderick","year":"2016"},{"key":"10.1016\/j.prrv.2017.06.012_b0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0960-894X(02)00851-X","article-title":"Development of an orexin-2 receptor selective agonist, [Ala (11), D-Leu(15)orexin-B","volume":"13","author":"Asahi","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.prrv.2017.06.012_b0175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/psc.716","article-title":"Structural properties of orexins for activation of their receptors","volume":"12","author":"Lang","year":"2006","journal-title":"J Pept Sci"},{"issue":"7","key":"10.1016\/j.prrv.2017.06.012_b0180","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1460-9568.2008.06446.x","article-title":"Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice","volume":"28","author":"Liu","year":"2008","journal-title":"Eur J Neurosci"},{"issue":"16","key":"10.1016\/j.prrv.2017.06.012_b0185","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1523\/JNEUROSCI.6069-10.2011","article-title":"Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice","volume":"31","author":"Liu","year":"2011","journal-title":"J Neurosci"},{"issue":"16","key":"10.1016\/j.prrv.2017.06.012_b0190","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.17-16-06401.1997","article-title":"Effects of thyrotropin- releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy","volume":"17","author":"Nishino","year":"1997","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.prrv.2017.06.012_b0195","first-page":"55","article-title":"Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness","volume":"35","author":"Inocente","year":"2012","journal-title":"Clin Pharmacol"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054217300684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054217300684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T07:38:04Z","timestamp":1569483484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054217300684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"alternative-id":["S1526054217300684"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2017.06.012","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of narcolepsy and other organic hypersomnias in children","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2017.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}